P1696: ECONOMIC BURDEN IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) FOR PATIENTS WITH ≥2 PRIOR LINES OF THERAPY INCLUDING A BRUTON TYROSINE KINASE INHIBITOR (BTKI) AND/OR B-CELL LYMPHOMA 2 INHIBITOR (BCL2I)
| Autor: | Masoom Priyadarshini, Gaurav Deshpande, Simran K Tiwana, T. Kim Le, Sean Garrison, Farrukh Awan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | HemaSphere, Vol 7, p e8677199 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2572-9241 |
| DOI: | 10.1097/01.HS9.0000973656.86771.99 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text